EUVIMEDEUVIMED entdecken
Open Access

Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India

Sudalaimuthu Mathan Kumar, Saravanan Essakky, Subramania R Rajasulochana, Sitanshu Sekhar Kar iD, Parthibane Sivanatham, Jeyanthi Anandraj, Sreejith Parameswaran, Biju Soman, Kavitha Rajsekhar, Antony Stanley

International Journal of Technology Assessment in Health Care · 2023

DOI: 10.1017/s0266462323002623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Technology Assessment in Health Care, 2023. Verfasst von Sudalaimuthu Mathan Kumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Kidney Failure, Chronic, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Patients with diabetes have a higher risk of developing chronic kidney disease (CKD). Early detection of CKD through microalbuminuria screening, followed by treatment, delays the progression of CKD. We evaluated the cost-effectiveness of population-based screening of microalbuminuria among normotensive type 2 diabetes mellitus patients aged >40 years compared with no screening scenario using a decision tree combined with the Markov model.

Methods

We considered two scenarios: Scenario I – dipstick microalbuminuria followed by spot-urine albumin–creatinine ratio (ACR) and serum creatinine in sequence; Scenario II – spot urine ACR plus serum creatinine. A mathematical cohort of the target population was simulated over a lifetime horizon with an annual cycle. Data for the model were obtained from secondary resources. The incremental cost-effectiveness ratios (ICERs) were estimated for screening scenarios compared to nonscreening scenario, along with sensitivity analyses.

Results

The discounted ICER per quality-adjusted life years gained for annual microalbuminuria screening in the normotensive diabetic population in India were ₹ 24,114 (US$ 308) and ₹ 13,790 (US$ 176) for scenarios I and II, respectively. Annual screening by scenarios I and II resulted in a reduction of 180 and 193 end-stage renal disease (ESRD) cases per 100,000 population, respectively, resulting in a cost saving of ₹ 12.3 and 13.3 Crore spent on ESRD management over 10 years. Both scenarios were also cost-effective even at the screening frequencies of 5 and 10 yearly.

Conclusion

Microalbuminuria screening was cost-effective at the threshold of one-time GDP per capita in India.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Kidney Failure, ChronicRenal Insufficiency, ChronicHumansCost-Benefit AnalysisCreatinineMass ScreeningQuality-Adjusted Life Years

Stichwörter der Autor:innen

chronic kidney diseasecost-effectiveness analysiseconomic evaluationpopulation-based screeningtype 2 diabetes mellitus

Substanzen

Creatinine

Autor:innen und Institutionen

  • Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
  • Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
  • Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India.
  • Department of Health Research, Government of India, New Delhi, India.

ORCID-Profile: Sitanshu Sekhar Kar

Zitieren

APA

Mathan Kumar, S., Essakky, S., Rajasulochana, S. R., Kar, S. S., Sivanatham, P., Anandraj, J., Parameswaran, S., Soman, B., Rajsekhar, K., & Stanley, A. (2023). Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462323002623

Vancouver

Mathan Kumar S, Essakky S, Rajasulochana SR, Kar SS, Sivanatham P, Anandraj J, et al. Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India. International Journal of Technology Assessment in Health Care. 2023. doi:10.1017/s0266462323002623

BibTeX
@article{MathanKumar2023,
  author = {Mathan Kumar, Sudalaimuthu and Essakky, Saravanan and Rajasulochana, Subramania R and Kar, Sitanshu Sekhar and Sivanatham, Parthibane and Anandraj, Jeyanthi and Parameswaran, Sreejith and Soman, Biju and Rajsekhar, Kavitha and Stanley, Antony},
  title = {Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India},
  journal = {International Journal of Technology Assessment in Health Care},
  year = {2023},
  doi = {10.1017/s0266462323002623}
}
Kostenlos starten →